There is a paucity of data available for the use of Total Femoral Arthroplasty (TFA) for joint reconstruction in the non-oncological setting. The aim of this study was to evaluate TFA outcomes with minimum 5-year follow-up.

This was a retrospective database study of TFAs performed at a UK tertiary referral revision arthroplasty unit. Inclusion criteria were patients undergoing TFA for non-oncological indications. We report demographics, indications for TFA, implant survivorship, clinical outcomes, and indications for re-operation.

A total of 39 TFAs were performed in 38 patients between 2015–2018 (median age 68 years, IQR 17, range 46–86), with 5.3 years’ (IQR 1.2, 4.1–18.8) follow-up; 3 patients had died. The most common indication (30/39, 77%) for TFA was periprosthetic joint infection (PJI) or fracture-related infection (FRI); and 23/39 (59%) had a prior periprosthetic fracture (PPF). TFA was performed with dual-mobility or constrained cups in 31/39 (79%) patients. Within the cohort, 12 TFAs (31%) required subsequent revision surgery: infection (7 TFAs, 18%) and instability (5 TFAs, 13%) were the most common indications. 90% of patients were ambulatory post-TFA; 2 patients required disarticulation due to recurrent PJI. While 31/39 (79%) were infection free at last follow-up, the remainder required long-term suppressive antibiotics.

This is the largest series of TFA for non-oncological indications. Though TFA has inherent risks of instability and infection, most patients are ambulant after surgery. Patients should be counselled on the risk of life-long antibiotics, or disarticulation when TFA fails.

Introduction

We are a high-volume arthroplasty unit performing over 800 primary THRs annually at an approximate reimbursement of £6.5 million to the Trust. 70% are hybrid and we have been using the Taperfit - Trinity combination (Corin, Cirencester) since March 2016. We aimed to investigate the potential cost-savings and clinical benefits of instrument rationalisation using this system following GIRFT principles.

Aims

Advocates of debridement, antibiotics and implant retention (DAIR) in hip periprosthetic joint infection (PJI) argue that a procedure not disturbing a sound prosthesis-bone interface is likely to lead to better survival and functional outcome compared with revision. This case-control study aims were to compare outcome of DAIRs for infected primary total hip arthroplasty (THA) with outcomes following primary THA and two-stage revision of infected primary THAs.

Aim

Advocates of Debridement-Antibiotics-and-Implant-Retention (DAIR) in hip peri-prosthetic joint infection (PJI) argue that a procedure not disturbing a sound prosthesis-bone interface is likely to lead to better survival and functional outcome compared to revision. However, no evidence supports this. This case-control study's aims were to compare outcome of DAIRs for infected 1° total hip arthroplasty (THA) with outcomes following 1° THA and 2-stage revisions of infected 1° THAs.

Introduction

The burden of peri-prosthetic joint infection (PJI) following hip and knee surgery is increasing. Endoprosthetic replacement (EPR) is an option for management of massive bone loss resulting from infection around failed lower limb implants.

Introduction

Native hip joint infection can result in hip arthrosis as a complication requiring the need for subsequent arthroplasty. There is little evidence to support single or staged THA. We present the results of patients who have undergone total hip arthroplasty (THA) following hip joint sepsis in our institution.

Introduction

The value of Debridement-Antibiotics-and-Implant-Retention (DAIR) in prosthetic-joint-infection (PJI) is still a matter of debate as most studies to-date are underpowered with variable end-points. In our, tertiary referral, bone infection unit we consider DAIR to be a suitable option in all PJIs with soundly fixed prostheses, despite chronicity. The aims of this study were to define the long-term outcome following DAIR in hip PJI and identify factors that influence it.

Debridement, antibiotics and implant retention (DAIR) is a surgical option in the treatment of prosthetic joint infection (PJI). It is thought to be most appropriate in the treatment of early (≤6 weeks post-op) PJI. Most studies to-date reporting on DAIRs in hip PJI have been underpowered by reporting on small cohorts (n= <45), or report on registry data with associated biases and limitations. In our, tertiary referral, bone infection unit we consider DAIR to be a suitable option in all cases of PJI with a soundly fixed prosthesis, with early or late presentation, especially in patients who are too elderly or infirm to undergo major surgery.

Aim: To define the 10-year outcome following DAIR in hip PJI and identify factors that influence it.

We retrospectively reviewed all DAIRs performed in our unit between 1997 and 2013 for hip PJI. Only infected cases confirmed by histological and microbiological criteria were included. Data recorded included patient demographics and medical history, type of surgery performed (DAIR or DAIR + exchange of modular components), organism identified and type/duration of antibiotic treatment. Outcome measures included complications, mortality rate, implant survivorship and functional outcome.

121 DAIRs were identified with mean age of 71 years (range: 33–97). 67% followed an index procedure of 1° arthroplasty. 53% included exchange of modular components. 60% of DAIRs were for early onset PJI. Isolated staphylococcus was present in 50% of cases and 25% had polymicrobial infection. At follow-up (mean:7 years, range: 0.3 – 18), 83 patients were alive; 5- and 10- year mortality rates were 15% and 35% respectively. 45% had a complication (persistence of infection: 27%, dislocation: 10%) and 40% required further surgery. Twenty hips have been revised to-date (17%). Performing a DAIR and not exchanging the modular components was associated with an almost 3× risk (risk ratio: 2.9) of subsequent implant failure (p=0.04). 10-yr implant survivorship was 80% (95%CI: 70 – 90%). Improved 10-year implant survivorship was associated with DAIR performed for early PJI (85% Vs 68%, p=0.04). Functional outcome will be discussed.

DAIR is a particularly valuable option in the treatment of hip PJI, especially in the early post-operative period. Whenever possible, exchange of modular implants should be undertaken, however DAIRs are associated with increased morbidity even in early PJI. Factors that predict success of DAIR in late PJI need to be identified.

Introduction

Subtle deformities of the acetabulum and proximal femur are recognised as biomechanical risk factors for the development of hip osteoarthritis (OA) as well as a cause of hip and groin pain. We undertook this study to examine relationships between a number of morphological measurements of the acetabulum and proximal femur and the hip pain in a 20-year longitudinal study.

Recent events have highlighted the importance of implant design for survival and wear-related complications following metal-on-metal hip resurfacing arthroplasty. The mid-term survival of the most widely used implant, the Birmingham Hip Resurfacing (BHR), has been described by its designers. The aim of this study was to report the ten-year survival and patient-reported functional outcome of the BHR from an independent centre.

In this cohort of 554 patients (646 BHRs) with a mean age of 51.9 years (16.5 to 81.5) followed for a mean of eight years (1 to 12), the survival and patient-reported functional outcome depended on gender and the size of the implant. In female hips (n = 267) the ten-year survival was 74% (95% confidence interval (CI) 83 to 91), the ten-year revision rate for pseudotumour was 7%, the mean Oxford hip score (OHS) was 43 (sd 8) and the mean UCLA activity score was 6.4 (sd 2). In male hips (n = 379) the ten-year survival was 95% (95% CI 92.0 to 97.4), the ten-year revision rate for pseudotumour was 1.7%, the mean OHS was 45 (sd 6) and the mean UCLA score was 7.6 (sd 2). In the most demanding subgroup, comprising male patients aged < 50 years treated for primary osteoarthritis, the survival was 99% (95% CI 97 to 100).

This study supports the ongoing use of resurfacing in young active men, who are a subgroup of patients who tend to have problems with conventional THR. In contrast, the results in women have been poor and we do not recommend metal-on-metal resurfacing in women. Continuous follow-up is recommended because of the increasing incidence of pseudotumour with the passage of time.

Introduction

Since the introduction of 3rd generation Metal-on-Metal-Hip-Resurfacing-Arthroplasty (MoMHRA), thousands of such prostheses have been implanted worldwide in younger patients with end-stage hip osteoarthritis. However, no independent centre has reported their medium-to-long term outcome. The aim of this study is to report the ten year survival and outcome of the Birmingham Hip Resurfacing (BHR), the most commonly used MoMHRA worldwide.

INTRODUCTION

Femoral neck narrowing (NN) following Metal-on-Metal Hip Resurfacing Arthroplasty (MoMHRA) is a well-recognised clinical phenomenon. The incidence of resurfaced hips with NN > 10% is reported to be up to 27%. Its pathogenesis is thought to be multi-factorial secondary to stress shielding, impingement, osteolysis secondary to wear/ion particles and as a result of reduced vascularity and pressure effect on cancellous bone secondary to the presence of a soft-tissue mass around the resurfaced hip. Recognised risk factors for its development include: female gender and the presence of a pseudotumour. Serum Chromium (Cr) and Cobalt (Co) are recognised surrogate markers of in-vivo wear of MoMHRA. The aims of this study were to establish whether NN is associated with increased wear.

INTRODUCTION

Studies have suggested that there is a reduction in head-neck-ratio (HNR) associated with MoMHRA. A reduction in HNR at operation would decrease range of movement and increase impingement risk. Impingement could lead to 20 edge loading, increasing wear. Serum ion levels of Chromium (Cr) and Cobalt (Co) are surrogate markers of wear. Although acetabular component orientation has been shown to contribute to wear and PT development, the role of a decrease in HNR has only been highlighted in PT development. This study aimed to measure changes in HNR that occur at resurfacing and determine any gender- and component size-specific differences. In addition it aimed to determine whether changes in HNR could be associated with increased wear.

Introduction: Metal-on-metal-hip-resurfacing-arthroplasty (MoMHRA) has been associated with the development of inflammatory pseudotumours(IP), especially in females. IPs have been linked to wear debris, which can be related to metal-ion blood levels. Acetabular component position has been shown to influence wear. We have identified an optimum component orientation minimising IP risk around an inclination/anteversion of 40°/20°±10°. Our aim was to see if this optimal position results in lower metal ions and to identify the boundary of an optimal placement zone for low wear.

Methods: A cohort of 104 patients(60M:44F) with unilateral MoMHRA was studied. Blood tests were obtained at a mean follow up of 3.9 years and serum Co/Cr levels were measured(ICPMS). High metal ion concentrations were defined as Co> 4.1ppb and Cr> 5.2ppb. Radiographic cup inclination/anteversion were measured using EBRA. The differences in ion levels between different orientation zones were investigated. Three orientation zones were defined centered on 40°/20°: Z1-within ±5°, Z2-outside ±5°/within ±10° and Z3-within ±10°.

Results: There was a wide range of cup placements. Females had significantly (p< 0.001) smaller components(mean:51, 44–60) than males(mean: 56, 52–64). Cr levels, but not Co, were higher in females(p=0.002) and those with small femoral components(< 50mm, p =0.03). Patients with cups within Z1 (n=13) had significantly lower Co(p=0.005) and Cr(p=0.001). Males with cups within Z3(n=27) had lower ion levels in comparison to those outside, which were significantly lower for Co(p=0.049) but not Cr(p=0.084). Females had similar ion levels within and out of Z3(Cr/Co: p=0.83/0.84). Co levels were significantly lower in Z1(n=13) in comparison to Z2(n=33)(p=0.048) but Cr levels were not different (p=0.06).

Discussion: MoMHRA cups placed within ±5° of the optimum(40°/20°) had significantly lower metal ions indicating lower wear within this narrow zone. This safe zone, could extend to ±10° for males only. The narrower safe zone coupled with smaller components implanted are possible factors contributing to the increased IP incidence seen in females.

Introduction: The use of highly cross-linked polyethylene (HXLPE) is now commonplace for total hip arthroplasty, however there is no long-term data to support its use. Hip simulator studies suggest that the wear rate of some types of HXLPE is ten times less than conventional polyethylene (UHMWPE). The outcomes of hip simulator studies are not always reproduced in vivo and there is some evidence that HXLPE wear may increase between 5 and 7 years.

Method: A prospective double blind randomised control trial was conducted using Radiostereometric Analysis (RSA). Fifty-four subjects were randomised to receive hip replacements with either UHMWPE liners or HXLPE liners. All subjects received a cemented CPT stem and uncemented Trilogy acetabular component (Zimmer, Warsaw, IN, USA). The 3D penetration of the head into the socket was determined to a minimum of 7 years.

Results: The total liner penetration was significantly different at 7 years (p=0.005) with values of 0.33 mm (SE 0.05 mm) for the HXLPE group and 0.55 mm (SE 0.05 mm) for the UHMWPE group. The steady state wear rate from 1 year onwards was significantly lower for HXLPE (0.005 mm/yr, SE 0.007 mm/yr) than for UHMWPE (0.037 mm/yr, SE 0.009 mm/yr) (p=0.007). The direction of wear was supero-lateral.

Discussion: We have previously demonstrated that the penetration in the first year is creep-dominated, from one year onwards the majority of penetration is probably due to wear. This study confirms the predictions from hip simulator studies which suggest that the wear rate of this HXLPE approaches that of metal-on-metal and ceramic-on-ceramic articulations. HXLPE may have the potential to reduce the need of revision surgery, due to wear debris induced osteolysis. It may also enable surgeons to use larger couples, thus reducing the risk of impingement and dislocation.

Introduction: Metal on metal hip resurfacing arthroplasty(MoMHRA) is an alternative option to THR in the treatment of young adults with OA. A recognised MoMHRA complication is the development of an inflammatory pseudotumour(IP). Diagnosis is made with the aid of US and/or MRI. To-date, no radiographic indication of the presence of IP has been identified. Neck thinning is a recognised phenomenon in MoMHRA hips not associated with any adverse clinical events. Its pathogenesis is considered multi-factorial. Our aim was to establish whether excessive neck narrowing is associated with the presence of a pseudotumour.

Methods: Twenty-seven hips (26 patients) with IP confirmed clinically, radiologically, intra-operatively and histologically were matched for sex, age, pre-operative diagnosis, component size and follow-up with an asymptomatic MoMHRA cohort (Control n=60). For all patients, prosthesis-neck-ratio(PNR) was measured on plain AP pelvic radiographs post-operatively and at follow-up as previously described and validated.

Results: All IP patients (4M:23F) and all (12M:48F) but two controls had a posterior approach at the time of MoMHRA. Post-operatively, there was no difference in the PNR between the two groups (p=0.19). At an average follow up of 3.5 years (range:0.7–8.3), IP patients(mean 1.26, 1.10–1.79) had a significantly higher (p< 0.0001) PNR in comparison to their controls(mean 1.14, 1.03–1.35). Greater neck narrowing occurred in both genders. IP necks had narrowed by an average of 8% (range:3–23). The degree of neck narrowing was correlated with length of survival of implant (p=0.001).

Discussion: This study shows a strong association between IP and neck narrowing. Processes such as impingement and increased wear are considered to be involved in the pathogenesis of both IP and neck narrowing. Furthermore, the presence of an IP, could lead to altered vascularity via a mass effect and further contribute to neck narrowing. Neck narrowing in symptomatic MOMHRA patients should alert surgeons of the possible presence of IP.

Metal on metal hip resurfacing (MMHR) is a popular procedure for the treatment of osteoarthritis in young patients. Several centres have observed masses, arising from around these devices, we call these inflammatory pseudotumours. They are locally invasive and may cause massive soft tissue destruction. The aim of this study was to determine the incidence and risk factors for pseudotumours that are serious enough to require revision surgery.

In out unit, 1,419 MMHRs were performed between June 1999 and November 2008. All revisions were identified, including all cases revised for pseudotumour. Pseudotumour diagnosis was made by histological examination of samples from revision. A Kaplan-Meier survival analysis was performed, Cox regression analysis was used to estimate the independent effects of different factors.

The revision rate for pseudotumour increased with time and was 4% (95% CI: 2.2% to 5.8%) at eight years. Female gender was a strong risk factor: at eight years the revision rate for pseudotumours in men was 0.5% (95% CI 0% to 1.1%), in women over 40 it was 6% (95% CI 2.3% to 10.1%) and in women under 40 it was 25% (95% CI 7.3% to 42.9%) (p< 0.001). Other factors associated with an increase in revision rate were, small components (p=0.003) and dysplasia (p=0.019), whereas implant type was not (p=0.156).

We recommend that resurfacings are undertaken with caution in women, especially those younger than 40 years of age, but they remain a good option in men. Further work is required to understand the patho-aetiology of pseudotumours so that this severe complication can be avoided.

Deep prosthetic joint infection remains an uncommon but serious complication of total hip replacement. We reviewed 24 patients with recalcitrant hip wounds following infected total hip replacement treated with either pedicled rectus femoris or vastus lateralis muscle flaps between 1998 and 2009. The mean age of the patients was 67.4 years (42 to 86) with ten men and 14 women.

There had been a mean of four (1 to 8) previous attempts to close the wound. A total of 20 rectus femoris and five vastus lateralis flaps were used, with one of each type of flap failing and requiring further reconstruction. All patients had positive microbiology. At a mean follow-up of 47 months (9 to 128), 22 patients had a healed wound and two had a persistent sinus. The prosthesis had been retained in five patients. In the remainder it had been removed, and subsequently re-implanted in nine patients. Six patients continued to take antibiotics at final follow-up.

This series demonstrates the effectiveness of pedicled muscle flaps in healing these infected wounds. The high number of previous debridements suggests that these flaps could have been used earlier.

Introduction: Metal-on-metal hip resurfacing arthroplasty (MoMHRA) has gained popularity as an alternative to THR for younger patients with osteoarthritis. A growing concern has been the association of MoMHRA with the development of inflammatory pseudotumours (IP), especially in women. These have been linked to metal-on-metal wear, which can be related to metal ion concentrations. Elevated metal wear debris levels may result from impingement, rim contact and edge loading. Head-neck ratio (HNR) is a predetermining factor for range of movement and impingement. Neck thinning is a recognised phenomenon post-MoMHRA and we have found an association of IP with increased neck thinning based on a case control study. Our aims were to identify HNR changes a hip undergoes when resurfaced and at follow up; and whether greater neck thinning at follow-up could be associated with the presence of elevated metal ions.

Methods: A cohort of 91 patients (57M:34F) with unilateral MoMHRAs were included in this study. Blood tests were obtained at a mean follow up of 3.9 years (range 1.7–7 years) and serum (Co:Cr) ion levels were measured (ICPMS). High metal ion concentrations were defined as Co> 4.1ppb and Cr> 5.2ppb. For all patients, head-neck ratio (HNR) was measured on plain anterio-posterior pelvic radiographs pre-operatively, immediately post-operatively and at follow-up.

Results: Female patients had significantly bigger HNR pre-op (mean=1.35, range:1.22–1.64) compared to males(mean=1.22, range:1.05–1.38) (p< 0.01). Immediately post-op, female HNRs (mean: 1.26, range: 1.14–1.34) were not different to male patients(mean=1.24, range=1.11–1.38) (p=0.11). At follow-up HNR was once again significantly bigger (p< 0.01) in females (mean=1.35, range: 1.21–1.49), compare to males (mean=1.27, range:1.11–1.38). HNR alterations with operation (p=0.00) and at follow-up (p< 0.01) were significantly bigger in female patients. Furthermore, there was a significant correlation between high ion levels and HNR change at follow-up for both Co (p=0.02) and Cr (p< 0.01).

Conclusion: This study identified gender-specific changes in HNR that resurfaced hips undergo, not previously documented. Female hips have greater HNR pre-operatively, compared to male hips, and appear to be biomechanically disadvantaged when resurfaced. A decrease in HNR with resurfacing could result in impingement and lead to processes, known to be more prevalent in females, such as neck thinning, increased wear and IP development. In addition, we highlight a correlation between high ion levels and greater neck thinning at follow-up. Increased neck thinning in symptomatic MoMHRA hips could be secondary to increased wear and should be investigated further radiologically for the presence of IP.

Introduction: Metal-on-metal hip resurfacing arthroplasty (MoMHRA) has gained popularity as an alternative to THR for younger patients with osteoarthritis. A growing concern has been the association of MoMHRA with the development of inflammatory pseudotumours (IP), especially in women. These have been linked to metal-on-metal wear, which can be related to metal ion concentrations. Although cup orientation has been shown to influence wear, the optimum cup position has not been clearly defined. We have identified an optimal cup orientation to minimise IP risk, based on a case controlled study, for inclination/anteversion within ±10° of 40°/20°. Our aim was to see if this optimal position results in lower metal ions, and to identify the boundary of an optimal placement zone for low wear.

Methods: A cohort of 104 patients (60M: 44F) with unilateral MoMHRA was included in this study. Blood tests were obtained at a mean follow up of 3.9 years (range 1.7–7 years) and serum Co and Cr ion levels were measured (ICPMS). High metal ion concentrations were defined as Co> 4.1ppb and Cr> 5.2ppb. Radiographic cup inclination and anteversion were measured using EBRA. The differences in ion levels between different cup orientation zones were investigated. Three orientation zones were defined centered on the target orientation of 40°/20°: Z1 within ±5°, Z2 outside ±5°/within ±10° and Z3: within ±10°.

Results: There was a wide range of cup placements; mean inclination/anteversion were 46.3°(21.5°–64.6°)/15°(2.7°–35.6°). Cr levels, but not Co, were higher in female patients (p=0.002) and those with small femoral components (< 50mm, p =0.03).

For the whole cohort, there was no significant difference in ion levels (Cr: p=0.092. Co=0.075) between cups positioned within Z3 (n=58) versus those outside (n=46 mean). Male patients with cups within Z3 (n=27) had lower ion levels in comparison to those outside Z3, which were significantly lower for Co (p=0.049) but not Cr (p=0.084). Female patients had similar levels within and out of Z3 for both ions (Cr: p=0.83, Co: p=0.84). However, patients with cups within Z1 (n=13) had significantly lower Co (p=0.005) and Cr (p=0.001) than those outside Z1 (n=95). Interestingly, Co levels were significantly lower in Z1 (n=13) in comparison to Z2 (n=33) (p=0.048) but Cr levels were not different (p=0.06).

Discussion: MoMHRA cups placed with ±5° of the ideal position of 40°/20°gave rise to significantly lower metal ions indicating lower wear within this narrow zone, in both sexes. This safe zone, could be extended to ±10° for male patients only. Gender specific factors, such as pelvic anatomy and joint flexibility, could be responsible for the narrower ‘safe’ zone seen in females. The narrower safe zone coupled with smaller components implanted are factors contributing to higher ion levels and hence the increased incidence of IP seen in females.